Skip to main content
. 2017 Nov 19;7(11):e018795. doi: 10.1136/bmjopen-2017-018795

Table 3.

EOGBS rates in the prescreening, screening and postscreening periods

Time period EOGBS n/N EOGBS/1000 cases (95% CI)
Prescreening (2009–2013) 25/25 276 0.99 (0.64 to 1.46)
Screening (2014–2015) 3/9098 0.33 (0.07 to 0.96)
Postscreening (2016–2017) 9/5033 1.79 (0.82 to 3.39)

EOGBS, early-onset group B Streptococcus.